Doctor Care Anywhere Group PLC (ASX: DOC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Doctor Care Anywhere Group PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Doctor Care Anywhere Group PLC (ASX: DOC)
Latest News
Share Gainers
These 4 small ASX shares are already up more than 19% in 2024!
Share Market News
Reason for hope as 'worst month of the year' starts off badly
Growth Shares
Is it time to buy these 2 beaten-up ASX shares in April 2022?
Growth Shares
Are these 2 top ASX growth shares buys?
Technology Shares
2 top ASX tech shares for February 2022
Technology Shares
2 ASX tech shares that are rapidly growing
Cheap Shares
Down 50%: Broker tips A2 Milk (ASX:A2M) and this ASX share to rebound in 2022
Small Cap Shares
2 small cap ASX shares for 2022 with big potential
Healthcare Shares
Why Doctor Care Anywhere (ASX:DOC) is soaring 12% today
Healthcare Shares
Why is the Doctor Care Anywhere (ASX:DOC) share price getting attention today?
Growth Shares
2 fast growth ASX shares that could be buys in December 2021
Growth Shares
2 ASX shares that may be too good to ignore
DOC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Doctor Care Anywhere Group PLC
Doctor Care Anywhere Group PLC is a telehealth company that provides clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. It utilizes its relationships with health insurers, healthcare providers, and corporate customers to connect with patients to deliver a range of telehealth services. The Group provides virtual healthcare services, technology platform licensing, and digital design services, within the United Kingdom, Australia, and the Republic of Ireland. The company derives a majority of its revenue from the UK and Ireland.
DOC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 02 Apr 2026 | $0.14 | $0.01 | 7.69% | 32,809 | $0.13 | $0.14 | $0.13 |
| 01 Apr 2026 | $0.13 | $-0.01 | -7.14% | 15,074 | $0.14 | $0.14 | $0.13 |
| 31 Mar 2026 | $0.14 | $0.00 | 0.00% | 16,024 | $0.13 | $0.14 | $0.13 |
| 30 Mar 2026 | $0.14 | $0.00 | 0.00% | 92,535 | $0.14 | $0.15 | $0.14 |
| 27 Mar 2026 | $0.14 | $0.00 | 0.00% | 8,926 | $0.15 | $0.15 | $0.14 |
| 26 Mar 2026 | $0.15 | $0.01 | 7.41% | 5,000 | $0.15 | $0.15 | $0.15 |
| 25 Mar 2026 | $0.14 | $0.01 | 8.00% | 10,000 | $0.14 | $0.14 | $0.14 |
| 24 Mar 2026 | $0.13 | $-0.01 | -7.41% | 819,446 | $0.14 | $0.14 | $0.12 |
| 23 Mar 2026 | $0.14 | $-0.01 | -7.14% | 25,053 | $0.14 | $0.14 | $0.14 |
| 20 Mar 2026 | $0.14 | $0.01 | 7.41% | 180,863 | $0.14 | $0.15 | $0.14 |
| 19 Mar 2026 | $0.14 | $-0.01 | -7.14% | 3,018 | $0.15 | $0.15 | $0.14 |
| 18 Mar 2026 | $0.14 | $0.00 | 0.00% | 750 | $0.14 | $0.14 | $0.14 |
| 17 Mar 2026 | $0.14 | $0.00 | 0.00% | 320,902 | $0.14 | $0.16 | $0.14 |
| 16 Mar 2026 | $0.14 | $0.00 | 0.00% | 37,131 | $0.14 | $0.14 | $0.14 |
| 13 Mar 2026 | $0.14 | $0.00 | 0.00% | 24,335 | $0.14 | $0.14 | $0.14 |
| 12 Mar 2026 | $0.14 | $0.00 | 0.00% | 146,563 | $0.15 | $0.15 | $0.13 |
| 11 Mar 2026 | $0.15 | $0.00 | 0.00% | 7,742 | $0.15 | $0.15 | $0.15 |
| 10 Mar 2026 | $0.15 | $-0.01 | -6.67% | 66,160 | $0.15 | $0.16 | $0.15 |
| 09 Mar 2026 | $0.15 | $0.01 | 7.14% | 150,872 | $0.14 | $0.15 | $0.14 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 08 Jan 2026 | John Stier | Buy | 500,000 | $73,183 |
On-market trade.
|
| 02 Sep 2025 | John Stier | Buy | 1,000,000 | $155,000 |
On-market trade. average
|
| 30 May 2025 | Laura O Riordan | Issued | 30,000,000 | $3,150,000 |
Issue of options.
|
| 07 May 2025 | John Stier | Buy | 500,000 | $41,760 |
On-market trade. average
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David Ravech | Non-Executive Director | Apr 2015 |
Mr Ravech also co-founded and chairs Rapid Health, which is an autonomous triage technology provider to NHS primary care organisations. Since 1998, David has led and invested in building disruptive technology companies from whiteboard etchings to reality. Prior to co-founding Doctor Care Anywhere, David was the founder and CEO of Overland Health, a technology-driven provider of rehabilitation services. He also founded Co-CEO Global Freight Exchange (GF-X) in 1998 which provided the airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight. GF-X was sold in 2007 to Descartes (Nasdaq: DSGX), a global provider of cloud-based logistics and supply chain management solutions). He then spent six years as a strategy management consultant at McKinsey, based in the Melbourne and London offices. He worked in Australia, the UK, Japan, Israel and several European countries, primarily serving clients in the retail, brewing, telecoms, medical device and banking sectors with a focus on mergers and acquisitions, competition law approvals and pricing strategy. He is a member of the Risk Committee.
|
| Mr John Robert Stier | Non-Executive ChairmanNon-Executive Director | May 2022 |
Mr Stier has experience in change management, M&A, and scaling businesses plus financial expertise gained in services-based industries. John built an executive career as a financial professional, becoming Group CFO of two technology- enabled services businesses Northgate Information Solutions plc and Equiniti plc. Northgate provide technology and outsourced solutions to the UK Government and global HR market, Equiniti is an international share registrar. John worked with these businesses for over twenty years, helping to build them both into FTSE 250 constituents on the London Stock Exchange. He is a member of the Risk Committee.
|
| Mr Matthew Addison | Non-Executive Director | Oct 2024 |
Mr Addison is both a repeat technology company founder and an investor. He is CEO of FinTech Step Ladder Solutions Ltd, founded in 2016 with backing from blue-chip growth investors including BBVA, Anthemis, Seedcamp and UK Future Fund. Prior to founding StepLadder, Matthew had a 15-year career in investment management with hedge funds Och-Ziff, Cheyne Capital, JCAM and Platinum Capital Management during which time he participated on several boards of portfolio companies undertaking recapitalizations, listings and M&A exit. He has experience of advising and managing companies and businesses in periods of strategic change.
|
| Ms Laura O Riordan | Chief Executive OfficerExecutive Director | Jan 2025 |
Ms ORiordan has latest role as President at eMed Healthcare UK (formally Babylon). Laura brings a wealth of leadership and digital healthcare knowledge from her previous roles at Babylon, The Good Care Group, Care UK and Harmoni.
|
| Professor Sam Shah | Non-Executive Director | Jan 2025 |
Prof Shah is a public health consultant and specialist in dental public health, with expertise in epidemiology, health regulation and corporate governance. He holds both clinical and legal qualifications and co- founded East Village Clinic Group, an NHS and private healthcare services organization. Professor Shah is Director of SAS Consultancy Services Limited (The Ivory Clinic) and EVD Group Holdings Limited (East Village Dental) and their respective subsidiaries. He is also a Non-Executive Director of the Private Healthcare Information Network, Director and advisor of Quiddity and Director of Health Data Management, NEOM. He has board level knowledge across the technology, investment, and global health ecosystem, having worked with organizations across Europe, North America, Middle East and Asia. He is Chair of the Risk Committee.
|
| Niall Dore | Interim Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| UBS Nominees Pty Ltd | 69,077,124 | 18.84% |
| Carani Holdings Limited | 44,264,604 | 12.07% |
| Thorney International Pty Ltd | 29,803,794 | 8.13% |
| Vijay Patel | 26,094,880 | 7.12% |
| Bgf Nominees Limited <Bgf Investments Lp A/C> | 18,042,248 | 4.92% |
| Buttonwood Nominees Pty Ltd | 16,532,682 | 4.51% |
| Bhikhu Patel | 8,698,178 | 2.37% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 8,211,800 | 2.24% |
| Patagorang Pty Ltd <Roger Allen Family A/C> | 8,191,201 | 2.23% |
| Gleneagle Securities Nominees Pty Limited | 6,497,000 | 1.77% |
| Lawn Views Pty Ltd <Angela Williams Family A/C> | 6,000,000 | 1.64% |
| Hadston 1 Llp\C | 4,829,815 | 1.32% |
| Bond Street Custodians Limited <Matzan D78834 A/C> | 4,469,743 | 1.22% |
| Jasforce Pty Ltd | 4,340,602 | 1.18% |
| Mr John Robert Stier | 4,000,000 | 1.09% |
| Mr Cornelius Donovan | 3,757,958 | 1.03% |
| Bgf Nominees Limited <Bgf Ventures Lp A/C> | 3,742,855 | 1.02% |
| Bond Street Custodians Limited <Delias D83505 A/C> | 3,175,407 | 0.87% |
| Indigenous Capital Limited | 3,116,420 | 0.85% |
| Spinite Pty Ltd | 2,798,650 | 0.76% |